Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study.
about
Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomesDesign and Implementation of the International Genetics and Translational Research in Transplantation NetworkThe urine microRNA profile may help monitor post-transplant renal graft function.Clinical aspects: focusing on key unique organ-specific issues of renal transplantation.Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes.Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure.Optimal cutoff point for immunoperoxidase detection of C4d in the renal allograft: results from a multicenter study.Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium.Challenges and considerations in diagnosing the kidney disease in deteriorating graft function.A case of late kidney allograft failure: a clinical pathological conference from American Society of Nephrology Kidney Week 2011.Lower calcineurin inhibitor doses in older compared to younger kidney transplant recipients yield similar troughsNovel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortiumThe Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant InjuryGenetic determinants of mycophenolate-related anemia and leukopenia after transplantation.Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study.Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy.Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update.Is it time to give up with calcineurin inhibitors in kidney transplantation?Calcineurin inhibitor sparing strategies in renal transplantation, part one: Late sparing strategies.Conversion from calcineurin inhibitor-based immunosuppression to mammalian target of rapamycin inhibitors or belatacept in renal transplant recipients.Chronic allograft rejection: a fresh look.The importance of non-HLA antibodies in transplantation.Late kidney dysfunction in a kidney transplant recipientBegin at the Beginning to Prevent the End.Recurrence of primary glomerulonephritis: Review of the current evidence.Recurrence of primary glomerulonephritis: Review of the current evidence.Adverse Events under Tacrolimus and Cyclosporine in the First 3 Years Post-Renal Transplantation in Children.The time dependency of renal allograft histology.Late graft failure after kidney transplantation as the consequence of late versus early events.The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion.Clinical and immunological features of very long-term survivors with a single renal transplant.Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomes.Effect of an Early Switch to Belatacept Among Calcineurin Inhibitor-Intolerant Graft Recipients of Kidneys From Extended-Criteria Donors.Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen.Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection.Impact of reduced exposure to calcineurin inhibitors on the development of de novo DSA: a cohort of non-immunized first kidney graft recipients between 2007 and 2014
P2860
Q28080994-8D09571C-F13D-44FF-A2D6-A33146C82A64Q30366188-EA449FF1-2867-4BB6-BFEB-D57AA09A9B0AQ30411597-F59BCF13-4B4A-4F0C-80E3-472645F8DBE1Q33412327-C031FBA9-9550-49C5-AE10-8E82AAF855B2Q33799767-8176607A-BBB3-4A82-9356-4AA0E3963D05Q33885388-5791AFF3-81FB-4B84-9A5E-C5D805A130F7Q34181871-E931D26C-EE94-4C29-ADD8-740ACF367099Q35210278-B8E2F6EC-E822-443C-A377-DC09A27E6ADEQ35823308-E15F737D-5AF7-4513-8A1A-6E37D96169C5Q36365811-10C8B8DE-46A9-458B-927B-44802A91E363Q36371094-D1A8F324-05B0-4A37-8824-B8CB79FA4DCEQ36442886-6A86BD48-FA0E-4231-AA1E-C6B31C34698CQ36630081-D43D3AD1-E948-494B-9C3E-99E153696D20Q36782862-5D944E3C-0537-4C2B-B162-4EAB37E67509Q37013588-F30F201C-52BC-42B3-8206-9A0E61AFDC2BQ37346593-991CE2C8-27A4-42CC-8892-40C91C0DA398Q37660263-6F17B65B-8E06-462C-BEEF-20B9A3FA5605Q38059865-8D163EA1-F7A2-4EFD-B637-142602D5B5AEQ38156847-F4B57061-04C1-4F21-8D46-52113E53DFDCQ38230449-E461F4FB-4FC9-4903-9AEE-BA6393E2A2A8Q38241710-BBA88CE9-B2ED-4B93-86E2-FC3500E83952Q38309271-178B13F7-FF25-4A36-8DF3-37FD238AAE0EQ38877375-52E19FEE-A6E6-40F1-A9F9-EC55C960FC86Q41834576-70F55EAF-B153-40CD-A98F-3960854D4E96Q42395013-BF8D8B9B-8F0E-4A89-A98A-966413AED920Q47193282-128B9480-4237-4992-A558-BC30428C855AQ47243136-AFF93918-C226-43F5-8B0B-28D735DC66E6Q47318170-C6EC95B1-2E03-4571-83C9-02507BF755C9Q48162490-E2619715-8E38-481F-8EDA-E5B223FFD78DQ50005462-3C1664A8-429B-4AAA-B7D8-635B144DF610Q50193450-E5821017-5CF2-426A-B32B-A7FB2E7897EBQ50966306-884C2FA0-781A-4C91-9ADF-8F6D5BBA3587Q51262438-D7DC5626-FF5D-4D53-85B1-5658E0A40AC9Q53803179-1C3095A4-A3A0-4E5B-B1C6-DC65F4471EC0Q54411021-A48E220E-DB36-469C-A865-49AFE80B2BEFQ55307350-4AF52687-22A4-4E78-BB80-7F2085082003Q58737637-7105F658-00A3-41D4-954C-23888975E408
P2860
Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pathological and clinical char ...... t': data from the DeKAF study.
@ast
Pathological and clinical char ...... t': data from the DeKAF study.
@en
Pathological and clinical char ...... t': data from the DeKAF study.
@nl
type
label
Pathological and clinical char ...... t': data from the DeKAF study.
@ast
Pathological and clinical char ...... t': data from the DeKAF study.
@en
Pathological and clinical char ...... t': data from the DeKAF study.
@nl
prefLabel
Pathological and clinical char ...... t': data from the DeKAF study.
@ast
Pathological and clinical char ...... t': data from the DeKAF study.
@en
Pathological and clinical char ...... t': data from the DeKAF study.
@nl
P2093
P2860
P1476
Pathological and clinical char ...... t': data from the DeKAF study.
@en
P2093
L Hunsicker
P2860
P304
P356
10.1111/J.1600-6143.2009.02954.X
P407
P577
2010-01-05T00:00:00Z